Company profile
Lattice Therapeutics company profile
Lattice Therapeutics aims to unlock gene and nucleic acid therapy’s transformative potential for medicine to both cure and prevent diseases. It creates a next-generation, non-viral, precision drug delivery platform that drives tomorrow’s life-changing outcomes. The company was founded in 2021 and is based in Washington, DC.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2021-01-01, Year
Headquarters
- Headquarters
- Novovasylivka, Mykolaiv, Ukraine
- Postal code
- 20012-2358
- Country code
- UA
- Continent
- Europe